Capecitabine (KAISER FOUNDATION HOSPITALS)


Welcome to the PulseAid listing for the Capecitabine drug offered from KAISER FOUNDATION HOSPITALS. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: KAISER FOUNDATION HOSPITALS
NON-PROPRIETARY NAME: Capecitabine
SUBSTANCE NAME: CAPECITABINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2014-05-14
END MARKETING DATE: 0000-00-00


Capecitabine HUMAN PRESCRIPTION DRUG Details:

Item DescriptionCapecitabine from KAISER FOUNDATION HOSPITALS
LABELER NAME: KAISER FOUNDATION HOSPITALS
DEA SCHEDULE:
ACTIVE STRENGTH: 500(mg/1)
START MARKETING DATE: 2014-05-14
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0179-0149_54ec910c-7486-4de2-ab26-b5d185939197
PRODUCT NDC: 0179-0149
APPLICATION NUMBER: ANDA091649

Other CAPECITABINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Accord Healthcare Inc.CAPECITABINE
American Health PackagingCapecitabine
Amneal Pharmaceuticals LLCCapecitabine
AvKARE, Inc.Capecitabine
Genentech, Inc.Xeloda
KAISER FOUNDATION HOSPITALSCapecitabine
Mylan Institutional Inc.Capecitabine
Mylan Pharmaceuticals Inc.Capecitabine
Northstar RxLLCCAPECITABINE
Physicians Total Care, Inc.Xeloda
Rising Pharmaceuticals, Inc.Capecitabine
Shilpa Medicare LimitedCapecitabine
State of Florida DOH Central PharmacyXeloda
Teva Pharmaceuticals USA, Inc.Capecitabine
West-Ward Pharmaceuticals Corp.Capecitabine